The 36-month beta value for PRFX is at 0.60. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for PRFX is 1.80M, and currently, shorts hold a 10.03% of that float. The average trading volume for PRFX on June 25, 2025 was 1.33M shares.
PRFX) stock’s latest price update
PainReform Ltd (NASDAQ: PRFX)’s stock price has decreased by -14.15 compared to its previous closing price of 1.47. However, the company has seen a -26.43% decrease in its stock price over the last five trading sessions. prnewswire.com reported 2025-05-27 that As a result of increased software sales by the acquirer, and in accordance with the terms of the software business sale agreement, a significant number of zero-exercise-price warrants have matured—Blade Ranger now holds approximately 1 million shares and warrants exercisable at no additional cost TEL AVIV, Israel, May 27, 2025 /PRNewswire/ — Blade Ranger Ltd. (TASE: BLRN), a company listed on the Tel Aviv Stock Exchange, announced the achievement of a first milestone in the transaction involving the sale of its DeepSolar operations to PainReform (NASDAQ: PRFX).
PRFX’s Market Performance
PRFX’s stock has fallen by -26.43% in the past week, with a monthly drop of -35.77% and a quarterly drop of -50.76%. The volatility ratio for the week is 4.67% while the volatility levels for the last 30 days are 4.18% for PainReform Ltd The simple moving average for the last 20 days is -31.05% for PRFX stock, with a simple moving average of -53.92% for the last 200 days.
PRFX Trading at -36.44% from the 50-Day Moving Average
After a stumble in the market that brought PRFX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.39% of loss for the given period.
Stock Fundamentals for PRFX
Current profitability levels for the company are sitting at:
- -1615028715258510.5 for the present operating margin
- -1372490106447.93 for the gross margin
The net margin for PainReform Ltd stands at -1736101949648716.8. The total capital return value is set at 9.23. Equity return is now at value -716.67, with -309.43 for asset returns.
Based on PainReform Ltd (PRFX), the company’s capital structure generated -0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -171.58. The debt to equity ratio resting at -0.03. The interest coverage ratio of the stock is -1372.83.
Currently, EBITDA for the company is -14.55 million with net debt to EBITDA at 0.17. When we switch over and look at the enterprise to sales, we see a ratio of -15415612805605.18. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.61.
Conclusion
In conclusion, PainReform Ltd (PRFX) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
